Prophylactic donor lymphocyte infusion reduces the risk of relapse and increases survival in patients with mixed T cell chimerism after reduced intensity allogeneic stem cell transplantation

被引：0
|
作者：
Buka, R. [1 ,2 ]
Nagra, S. [1 ]
Jenkin, P. [3 ]
Dean, N. [1 ]
Cook, M. [1 ]
Chaganti, S. [1 ]
Malladi, R. [1 ,2 ]
Craddock, C. [1 ,2 ]
机构：
[1] Queen Elizabeth Hosp, Ctr Clin Haematol, Birmingham, W Midlands, England
[2] Univ Birmingham, Birmingham, W Midlands, England
[3] NHS Blood & Transplant, Birmingham, W Midlands, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH2020-PO
引用
收藏
页码：177 / 177
页数：1
相关论文
共 50 条
  • [1] DONOR LYMPHOCYTE INFUSION FOR MIXED CHIMERISM AT 7 MONTHS AFTER T CELL DEPLETED ALLOGENEIC STEM CELL TRANSPLANTATION REDUCES RELAPSE RISK
    Marijt, W. A.
    von dem Borne, A.
    Barge, M. Y.
    Deutz-Terlouw, P.
    Beaumont, M.
    Starrenburg, C. W. J.
    Fibbe, E.
    Willemze, R.
    Falkenburg, J. H. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 241 - 241
  • [2] Donor Factors Influence Outcomes of Patients Receiving Donor Lymphocyte Infusion for Mixed Chimerism after Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation
    Soto, Jose Ros
    Snowden, John A.
    Szydlo, Richard
    Nicholson, Emma
    Madrigal, Alejandro
    Easdale, Sandra
    Ethell, Mark
    Potter, Mike
    Anthias, Chloe
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 551 - 551
  • [3] Prevention of relapse by donor lymphocyte infusion for mixed chimerism 7 months after T-cell depleted allogeneic stem cell transplantation
    Marijt, W.
    Baas, I.
    von dem Borne, P.
    Barge, R.
    Deutz, P.
    Beaumont, F.
    Starrenburg, I.
    Fibbe, W.
    Willemze, R.
    Falkenburg, J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S161 - S161
  • [4] Early Donor Chimerism Levels Predict Relapse and Survival after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning
    Reshef, Ran
    Hexner, Elizabeth O.
    Loren, Alison W.
    Frey, Noelle V.
    Stadtmauer, Edward A.
    Luger, Selina M.
    Mangan, James K.
    Gill, Saar I.
    Vassilev, Pavel
    Lafferty, Kathryn A.
    Smith, Jacqueline
    Van Deerlin, Vivianna M.
    Mick, Rosemarie
    Porter, David L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) : 1758 - 1766
  • [5] Comparison of second transplantation and donor lymphocyte infusion for donor mixed chimerism after allogeneic stem cell transplantation for nonmalignant diseases
    Umeda, Katsutsugu
    Adachi, Souichi
    Tanaka, Shiro
    Miki, Mizuka
    Okada, Keiko
    Hashii, Yoshiko
    Inoue, Masami
    Cho, Yuko
    Koh, Katsuyoshi
    Goto, Hiroaki
    Kajiwara, Ryosuke
    Hyakuna, Nobuyuki
    Kato, Koji
    Morio, Tomohiro
    Yabe, Hiromasa
    PEDIATRIC BLOOD & CANCER, 2016, 63 (12) : 2221 - 2229
  • [6] αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
    Kordelas, L.
    Buttkereit, U.
    Lindemann, M.
    Koldehoff, M.
    Klisanin, V.
    Horn, P. A.
    Fleischhauer, K.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2017, 52 (12) : 1668 - 1670
  • [7] αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
    L Kordelas
    U Buttkereit
    M Lindemann
    M Koldehoff
    V Klisanin
    P A Horn
    K Fleischhauer
    D W Beelen
    Bone Marrow Transplantation, 2017, 52 : 1668 - 1670
  • [8] Allogeneic stem cell transplantation in MDS: reduced intensity conditioning and donor lymphocyte infusion
    Kroeger, N.
    LEUKEMIA RESEARCH, 2009, 33 : S28 - S28
  • [9] Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML
    F Legrand
    A-C Le Floch
    A Granata
    S Fürst
    C Faucher
    C Lemarie
    S Harbi
    S Bramanti
    B Calmels
    J El-Cheikh
    C Chabannon
    P-J Weiller
    N Vey
    L Castagna
    D Blaise
    R Devillier
    Bone Marrow Transplantation, 2017, 52 : 620 - 621
  • [10] Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML
    Legrand, F.
    Le Floch, A-C
    Granata, A.
    Fuerst, S.
    Faucher, C.
    Lemarie, C.
    Harbi, S.
    Bramanti, S.
    Calmels, B.
    El-Cheikh, J.
    Chabannon, C.
    Weiller, P-J
    Vey, N.
    Castagna, L.
    Blaise, D.
    Devillier, R.
    BONE MARROW TRANSPLANTATION, 2017, 52 (04) : 620 - 621
12345